DelveInsight's Tumor-Infiltrating Lymphocyte Therapies Market Size, Target Population, Competitive Landscape & Market ...

In May 2025, the Company reported additional long-term data from its nonhuman primate (“NHP”) study that demonstrated durable and consistent FVIII activity levels through approximately 19 months. Mean ...

A research team headed by the University of Zurich has developed a powerful new method to precisely edit DNA by combining ...

In a discovery that could expand the array of current cancer immunotherapy treatments, scientists at Harvard Medical School ...

The AI tool, named “Pythia,” predicts how cells repair their DNA after CRISPR editing and opens the door to next-generation gene therapies.

CRISPR Therapeutics’ CRSP Casgevy, a one-shot gene therapy, was approved in late 2023 and early 2024 across the United States and Europe for two blood disorder indications — sickle cell disease (SCD) ...

A research team headed by the University of Zurich has developed a powerful new method to precisely edit DNA by combining ...

TB, a one-sample, parallelized reaction amplification and detection CRISPR assay that detects Mycobacterium tuberculosis ...

A Chinese scientist, He Jiankui, made a shocking announcement to the world in 2018: He had secretly engineered the birth of the first gene-edited babies. The birth of the twins was seen as reckless ...

Next-generation prime editing tool that uses two prime editing guide RNAs (pegRNAs) can make edits up to 100 base pairs long.

Scientists edit rice's regulatory DNA using CRISPR, increasing photosynthesis and water efficiency, promising more resilient crops.